Hints and tips:
...and vitamin B, and unlike some animal meat products did not contain hormones....
...“Oh, it’d be a lovely life, wouldn’t it?” he sighs. “Having all the animals and people around to see them.” He beams into the country air. “I’d love to have some cows knocking about.”...
...The next steps, which will take place mainly at Merck’s US R&D headquarters will be to optimise the chemical structure of a “lead compound” and, after further animal testing, take it through clinical trials...
...A striking example was its decision to collaborate with Merck on the development of Lynparza, handing the US company a 50 per cent share of the proceeds of one of its leading medicines....
...For Mr Read, who became chief executive in 2010, divesting the consumer business would mark the biggest shake-up of the company since it spun out its animal health unit in 2013, creating Zoetis, which now...
...Public health capacity — including human and animal disease surveillance — must be improved, as well as global efforts to accelerate R&D of vaccines, drugs and diagnostics....
...The review is also right to urge restraint on farmers who use antibiotics on a vast scale to prevent infection or promote growth rather than to treat sick animals....
...The declaration voiced support for a global plan set out by the World Health Organisation to reduce inappropriate use of antibiotics in humans and animals and highlighted the need for more accurate diagnostic...
...health unit....
...The VSV-EBOV vaccine has been developed in record time in response to the epidemic, by the Public Health Agency of Canada with two US companies, Merck and NewLink Genetics....
...Last week Mr Ackman identified Zoetis, the $22bn animal health group, as a potential acquisition target for Valeant. One person close to the Canadian group described Zoetis as a “Plan B acquisition”....
...Among them was Zoetis, the animal health group in which he recently amassed a stake and suggested as a Plan B target....
...By the same logic, GSK will acquire Novartis’s vaccine unit – including a breakthrough jab to prevent meningitis B – for up to $7.1bn, extending its lead over Sanofi, Merck and Pfizer in a fast-growing market...
...Sales from Merck’s animal health and consumer care division grew by 7 per cent and 8 per cent, respectively, during the first quarter compared with the same period a year ago....
...He picks Sanofi as a direct holding, for its seven growth opportunities: emerging markets, vaccines, consumer healthcare, diabetes, animal health, rare diseases and innovative products....
...venture after Merck’s purchase of Schering-Plough and its animal health division Intervet....
...the joint venture after Merck’s purchase of Schering-Plough and its animal health division Intervet....
...Merck, desperate to avoid the ire of competition regulators and to lock-in its $41bn acquisition of Schering-Plough, offloaded its half share in Merial, its animal health joint venture, to partner Sanofi...
...the Intervet/Schering-Plough animal health division in the process....
...The acquisition helped Pfizer diversify into new areas such as vaccines and animal health....
...The deal follows an agreement last year under which Sanofi-Aventis bought out Merial from Merck, after Merck purchased Schering-Plough for $41bn in 2009 and acquired the Intervet/Schering-Plough animal health...
..., which in turn had acquired the animal health business Intervet....
...European pharmaceutical group Sanofi-Aventis and Merck & Co in the US joined forces, hoping to become the world leader in the $19bn animal health market....
...On Thursday, they launched a two-step bid to overtake Pfizer as the leader in animal health. The deal is a clever one....
...in an expanded version of Merial, their joint venture for animal health....
International Edition